Abstract

BackgroundPatients with spontaneous or traumatic active mesenteric bleeding cannot be treated endoscopically. Transarterial embolization can serve as a potential alternative to emergency surgery. Literature on transarterial embolization for mesenteric bleeding remains very scarce. The objective of this study was to evaluate the safety and efficacy of transarterial embolization for mesenteric bleeding. We reviewed all consecutive patients admitted for mesenteric bleeding to the interventional radiology department, in a tertiary center, between January 2010 and March 2021. Mesenteric bleeding was defined as mesenteric hematoma and contrast extravasation and/or pseudoaneurysm visible on pre-operative CT scan. We evaluated technical success, clinical success, and complications.ResultsAmong the 17 patients admitted to the interventional department for mesenteric bleeding, 15 presented with active mesenteric bleeding requiring transarterial embolization with five patients with hemodynamic instability. Mean age was 67 ± 14 years, including 12 (70.6%) males. Technical success was achieved in 14/15 (93.3%) patients. One patient with technical failure was treated by percutaneous embolization with NBCA-Lipiodol mixture. Three patients (20%) had early rebleeding: two were treated by successful repeat embolization and one by surgery. One patient (6.7%) had early death within 30 days and two patients (13.3%) had late death after 30 days. Mean length of hospitalization was 12.8 ± 7 days. There were no transarterial embolization-related ischemic complications.ConclusionTransarterial embolization is a safe and effective technique for treating mesenteric bleeding even in patients with hemodynamic instability. Transarterial embolization doesn’t close the door to surgery and could be proposed as first intention in case of mesenteric bleeding.

Highlights

  • Mesenteric bleeding (MB) occurs rarely (Aoki et al, 1990) and its frequency is not well known

  • Transarterial embolization (TAE) has been reported to be effective in the treatment of gastrointestinal bleeding (Bua-ngam et al, 2017; Bond & Smith, 2019; Beggs et al, 2014), and predictive factors for rebleeding and death after TAE have been reported in this indication (Choi et al, 2020)

  • Study population We retrospectively reviewed all patients referred to our hospital for MB who were treated by TAE, based on clinical decisions in emergency and computed tomography (CT) images, between January 2010 and March 2021

Read more

Summary

Introduction

Mesenteric bleeding (MB) occurs rarely (Aoki et al, 1990) and its frequency is not well known It corresponds to bleeding from mesenteric vessels in the abdominal cavity, without intra-luminal digestive bleeding. TAE is valuable in identifying the specific bleeding site and achieving haemostasis by elective exclusion of the bleeding artery using temporary agents (gelatine sponge slurry) or permanent agents (coils, NBCA, micro-particles) It poses the potential risk of digestive ischemia (Nykänen et al, 2018). The purpose of this study is to report the safety and efficacy of emergency TAE for the treatment of mesenteric bleeding in a tertiary center. The objective of this study was to evaluate the safety and efficacy of transarterial embolization for mesenteric bleeding.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call